The immediate cardiovascular effects of pancuronium, alcuronium and tubocurarine in man.
D000328:Adult; D000498:Allyl Compounds / Q000494:pharmacology; D000731:Androstanes / Q000494:pharmacology*; D000768:Anesthesia, General; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002496:Central Venous Pressure / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D010197:Pancuronium / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014117:Toxiferine / Q000494:pharmacology*; D014403:Tubocurarine / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D000498:Allyl Compounds; D000731:Androstanes; D003473:Neuromuscular Nondepolarizing Agents; D001285:Atropine; D014117:Toxiferine; D010197:Pancuronium; D014403:Tubocurarine